The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast AsiaSAN ANTONIO, Dec. 15, 2025 /PRNewswire/…
40 women from tier two and three institutions selected for the third cohort of the programOver 50 women benefitted from the…
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…